| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 96.69B | 79.90B | 71.25B | 62.32B | 57.21B | 50.11B |
| Gross Profit | 20.37B | 16.57B | 15.53B | 15.66B | 12.93B | 11.31B |
| EBITDA | 9.19B | 5.49B | 5.22B | 6.16B | 3.98B | 3.58B |
| Net Income | 4.98B | 2.90B | 2.78B | 4.42B | 2.60B | 2.72B |
Balance Sheet | ||||||
| Total Assets | 149.50B | 152.10B | 124.15B | 116.54B | 95.71B | 76.05B |
| Cash, Cash Equivalents and Short-Term Investments | 36.20B | 22.47B | 34.90B | 34.15B | 27.70B | 22.65B |
| Total Debt | 82.42B | 86.81B | 59.02B | 57.86B | 48.65B | 32.59B |
| Total Liabilities | 112.82B | 118.12B | 92.18B | 86.54B | 69.14B | 50.23B |
| Stockholders Equity | 36.69B | 33.98B | 31.97B | 30.00B | 26.57B | 25.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -33.93B | -2.44B | 215.00M | -7.01B | -5.65B |
| Operating Cash Flow | 0.00 | -33.37B | -1.83B | 419.00M | -6.89B | -5.55B |
| Investing Cash Flow | 0.00 | -5.84B | 2.44B | -2.41B | -45.00M | 1.38B |
| Financing Cash Flow | 0.00 | 26.79B | 140.00M | 8.35B | 12.08B | 3.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥21.21B | -32.07 | ― | 3.54% | 36.88% | 83.47% | |
74 Outperform | ¥117.57B | 5.88 | ― | 2.93% | 20.83% | 57.13% | |
73 Outperform | ¥136.53B | 20.19 | 15.81% | 2.93% | 84.20% | 137.87% | |
71 Outperform | ¥91.59B | 14.58 | ― | 2.19% | 4.72% | 47.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥54.12B | 9.84 | ― | 0.45% | -8.33% | -36.89% | |
62 Neutral | ¥74.52B | 8.53 | ― | 2.89% | -3.09% | -35.66% |